Oi SA QIBRD
—
4.01
0.00
0.00%
as of 20 Nov
- Market cap
- —
- P/E
- 0.0×
Follow QIBRD
| Older periods | Dec '20 | Mar '21 | Jun '21 | Sep '21 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
1.64 | 2.12 | 3.45 | 6.48 | |
P/FCF ratio |
13.90 | 6.39 | 23.67 | 55.91 | |
P/Operating CF |
19.05 | (29.41) | (6.53) | 11.81 | |
P/B ratio |
1.96 | 3.09 | 2.22 | 8.36 | |
Price to Tangible BV |
3.74 | 17.72 | 5.19 | 0.00 | |
EV/Sales |
2.03 | 2.73 | 1.80 | 3.70 | |
EV/EBITDA |
7.44 | 10.25 | 5.67 | 21.87 | |
EV/Operating CF |
4.27 | 4.74 | 24.05 | (6.27) | |
EV/FCF |
17.19 | 8.21 | 12.32 | 31.89 | |
Quick Ratio |
1.63 | 1.26 | 1.50 | 1.80 | |
Current Ratio |
1.88 | 1.50 | 1.67 | 1.97 | |
Net Debt/EBITDA |
(1.75) | 2.85 | (10.79) | (7.87) | |
Debt/Assets |
38.83% | 39.04% | 38.74% | 44.72% | |
Debt/Equity |
3.69 | 6.60 | 4.94 | 31.30 | |
Asset Turnover |
0.11 | 0.08 | 0.05 | 0.02 | |
Operating CF/Net income |
0.31 | 0.13 | (1.75) | (0.16) | |
Capex/Depreciation |
(3.55) | (0.57) | 0.71 | (1.04) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
(11.69%) | 50.82% | 49.82% | 46.12% | |
Intangible Assets out of Total Assets |
0.05 | 0.05 | 0.04 | 0.04 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(2.12) | (2.56) | (1.93) | (3.12) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(69.62%) | (55.43%) | (18.30%) | (53.46%) | |
Free Cash Flow Yield |
7.19% | 15.64% | 4.23% | 1.79% | |
Revenue per Share |
(34.32) | 13.76 | 14.08 | 14.43 | |
Operating CF per Share |
5.35 | (2.76) | (12.55) | 4.91 | |
Capex per Share |
14.82 | (4.08) | 3.40 | (7.46) | |
Free Cash Flow per Share |
20.18 | (6.84) | (9.15) | (2.55) | |
Cash per Share |
167.84 | 150.42 | 222.07 | 242.13 | |
Shareholders Equity per Share |
52.01 | 26.30 | 37.01 | 6.94 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
52.01 | 26.30 | 37.01 | 6.94 | |
Free Cash Flow |
584.71 | (203.57) | (274.28) | (75.99) | |
Working Capital |
3,061.83 | 2,076.20 | 3,309.19 | 4,367.96 | |
Capital Expenditures |
429.56 | (121.39) | 101.97 | (222.10) | |
Net Current Asset Value |
(6,261.19) | (6,185.48) | (4,751.89) | (5,389.66) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.43 | 0.30 | (0.24) | 0.52 | |
Net Profit Margin |
(50.54%) | (156.55%) | 50.97% | (214.49%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
1,317.47 | 1,150.91 | 1,047.17 | 1,071.96 | |
Average Payables |
1,062.40 | 916.89 | 773.52 | 775.24 | |
Average Inventory |
76.83 | 76.64 | 69.46 | 68.86 | |
Average Assets |
16,358.22 | 14,962.66 | 13,891.44 | 13,989.58 | |
Average Common Equity |
3,287.90 | 1,701.24 | 1,315.96 | 661.83 |
Columns are period end dates